SHANDONG XINHUA: 2024 Interim Report
SHANDONG XINHUA: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
SHANDONG XINHUA: Overseas Regulatory Announcement-Announcement on Having Obtained the Notification of Approval of Supplementary Drug Application and Other Relevant Information
SHANDONG XINHUA: Overseas Regulatory Announcement-Announcement on Obtaining Approval Notice for Supplementary Drug Application and Other Relevant Information
SHANDONG XINHUA: Overseas Regulatory Announcement-Announcement on Esomeprazole Magnesium Having Obtained the Notification of Approval of Marketing Application for Chemical Substance Drugs
SHANDONG XINHUA: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 August 2024
SHANDONG XINHUA: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
SHANDONG XINHUA: Overseas Regulatory Announcement-Announcement on the Progress of Clinical Trial of OAB-14 Dry Suspension
SHANDONG XINHUA: Interim Dividend For the Six Months Ended 30 June 2024
SHANDONG XINHUA: Payment of 2024 Interim Dividend
SHANDONG XINHUA: 2024 Interim Results Announcement
SHANDONG XINHUA: Announcement Notice of Board Meeting
SHANDONG XINHUA: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 July 2024
SHANDONG XINHUA: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
SHANDONG XINHUA: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
SHANDONG XINHUA: Articles of Association
SHANDONG XINHUA: (I)Poll Results of The Annual General Meeting And of The Class Meeting of The Shareholders of H Shares; And (II)Payment of 2023 Final Dividend
SHANDONG XINHUA: Final dividend for the year ended 31 December 2023
SHANDONG XINHUA: Overseas Regulatory Announcement-Announcement on Pregabalin Capsules Having Obtained the Drug Registration Certificate
SHANDONG XINHUA: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024
No Data
No Data